An official website of the United States government
Home
Name
Thalidomide
Alternate Names
K-17
Kevadon
Synovir
Thalomid
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
Antiangiogenic agent for most indications
NSC Number
66847
Primary Site
Histology
None
Remarks
FDA approved for multiple myeloma 2006; Phase II brain, kidney, liver, lung, leukemia, HD, NHL, melanoma Phase III prostate Tumor Necrosis Factor inhibitor; angiogenesis inhibitor; immunomodulator. Celgene, NCI.
Coding
This drug should be coded
